| pubmed-article:2400915 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:2400915 | lifeskim:mentions | umls-concept:C0034693 | lld:lifeskim |
| pubmed-article:2400915 | lifeskim:mentions | umls-concept:C0005854 | lld:lifeskim |
| pubmed-article:2400915 | lifeskim:mentions | umls-concept:C0013254 | lld:lifeskim |
| pubmed-article:2400915 | lifeskim:mentions | umls-concept:C0442805 | lld:lifeskim |
| pubmed-article:2400915 | lifeskim:mentions | umls-concept:C0031164 | lld:lifeskim |
| pubmed-article:2400915 | lifeskim:mentions | umls-concept:C0024485 | lld:lifeskim |
| pubmed-article:2400915 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:2400915 | pubmed:dateCreated | 1990-10-23 | lld:pubmed |
| pubmed-article:2400915 | pubmed:abstractText | In a qualitative electron microscopy study we initially reported that exposure of rats to a standard clinical magnetic resonance imaging (MRI) procedure temporarily increased the blood-brain barrier (BBB) permeability to horseradish peroxidase. In this study, we quantitatively support our initial finding. Rats were injected intracardially with radio-labelled diethylenetriaminepentaacetic acid [( 153Gd]DTPA) in the middle of two sequential 23.2 min MRI exposures. Exposed rats (n = 21) showed significantly greater (29%, P = 0.006) retention of [153 Gd]DTPA than sham-exposed rats (n = 22) 1 h after the end of the last 23.2 min exposure. These findings suggest that magnetic fields may alter BBB permeability. | lld:pubmed |
| pubmed-article:2400915 | pubmed:language | eng | lld:pubmed |
| pubmed-article:2400915 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2400915 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:2400915 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2400915 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2400915 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2400915 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2400915 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2400915 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2400915 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:2400915 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:2400915 | pubmed:issn | 0006-8993 | lld:pubmed |
| pubmed-article:2400915 | pubmed:author | pubmed-author:LeeT YTY | lld:pubmed |
| pubmed-article:2400915 | pubmed:author | pubmed-author:ShiversR RRR | lld:pubmed |
| pubmed-article:2400915 | pubmed:author | pubmed-author:PratoF SFS | lld:pubmed |
| pubmed-article:2400915 | pubmed:author | pubmed-author:ZabelPP | lld:pubmed |
| pubmed-article:2400915 | pubmed:author | pubmed-author:KavaliersMM | lld:pubmed |
| pubmed-article:2400915 | pubmed:author | pubmed-author:DrostDD | lld:pubmed |
| pubmed-article:2400915 | pubmed:author | pubmed-author:FrappierJ RJR | lld:pubmed |
| pubmed-article:2400915 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:2400915 | pubmed:day | 23 | lld:pubmed |
| pubmed-article:2400915 | pubmed:volume | 523 | lld:pubmed |
| pubmed-article:2400915 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:2400915 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:2400915 | pubmed:pagination | 301-4 | lld:pubmed |
| pubmed-article:2400915 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:2400915 | pubmed:meshHeading | pubmed-meshheading:2400915-... | lld:pubmed |
| pubmed-article:2400915 | pubmed:meshHeading | pubmed-meshheading:2400915-... | lld:pubmed |
| pubmed-article:2400915 | pubmed:meshHeading | pubmed-meshheading:2400915-... | lld:pubmed |
| pubmed-article:2400915 | pubmed:meshHeading | pubmed-meshheading:2400915-... | lld:pubmed |
| pubmed-article:2400915 | pubmed:meshHeading | pubmed-meshheading:2400915-... | lld:pubmed |
| pubmed-article:2400915 | pubmed:meshHeading | pubmed-meshheading:2400915-... | lld:pubmed |
| pubmed-article:2400915 | pubmed:meshHeading | pubmed-meshheading:2400915-... | lld:pubmed |
| pubmed-article:2400915 | pubmed:meshHeading | pubmed-meshheading:2400915-... | lld:pubmed |
| pubmed-article:2400915 | pubmed:meshHeading | pubmed-meshheading:2400915-... | lld:pubmed |
| pubmed-article:2400915 | pubmed:meshHeading | pubmed-meshheading:2400915-... | lld:pubmed |
| pubmed-article:2400915 | pubmed:meshHeading | pubmed-meshheading:2400915-... | lld:pubmed |
| pubmed-article:2400915 | pubmed:meshHeading | pubmed-meshheading:2400915-... | lld:pubmed |
| pubmed-article:2400915 | pubmed:meshHeading | pubmed-meshheading:2400915-... | lld:pubmed |
| pubmed-article:2400915 | pubmed:meshHeading | pubmed-meshheading:2400915-... | lld:pubmed |
| pubmed-article:2400915 | pubmed:year | 1990 | lld:pubmed |
| pubmed-article:2400915 | pubmed:articleTitle | Magnetic resonance imaging increases the blood-brain barrier permeability to 153-gadolinium diethylenetriaminepentaacetic acid in rats. | lld:pubmed |
| pubmed-article:2400915 | pubmed:affiliation | Department of Nuclear Medicine, St. Joseph's Health Centre, London, Ont., Canada. | lld:pubmed |
| pubmed-article:2400915 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:2400915 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2400915 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2400915 | lld:pubmed |
